基础代谢率降低可作为老年男性肌少症与衰弱的客观标志物
该研究纳入305例接受老年综合评估的男性患者,用Fried标准评估衰弱、EWGSOP标准诊断肌少症、生物电阻抗分析计算基础代谢率(BMR)。结果显示肌少症与衰弱患者BMR降低更明显,BMR/BSA诊断肌少症的AUC为0.82,提示低BMR应 alert 筛查肌少症与衰弱。
要点
- 低BMR(<1612 kcal/d)者衰弱与肌少症比例均显著更高。
- BMR/BSA截断值874 kcal/m2诊断肌少症敏感度80%、特异度68%。
- 无肌少症者BMR/BSA更高,未调整OR=8.00、调整后OR=6.60。
核心结论
- 老年男性肌少症与衰弱患者BMR降低更明显,低BMR应提醒筛查肌少症与衰弱。
- BMR/BSA可能作为老年男性肌少症客观筛查的指标。
研究设计与样本
- 研究纳入305例接受老年综合评估的男性患者,平均年龄74.52±7.51岁。
- 衰弱用Fried标准评估,肌少症按EWGSOP标准诊断,BMR由生物电阻抗分析计算。
- 采用ROC曲线下面积(AUC)检验BMR检测肌少症的预测准确性。
主要发现
- 样本中95例(31.1%)有肌少症,55例(18%)有衰弱。
- BMR<1612 kcal/d者衰弱频率高于BMR≥1612 kcal/d者(67.3 vs 32.7,P<.001)。
- BMR<1612 kcal/d者肌少症频率也更高(77.9 vs 22.1,P<.001)。
- BMR/BSA诊断肌少症的AUC为0.82,截断值874 kcal/m2时敏感度80%、特异度68%(P<.01)。
- 无肌少症者BMR/BSA更高:未调整OR=8.00(95%CI 4.52-14.19,P<.001),调整后OR=6.60(95%CI 3.52-12.38,P<.001)。
关键数值与推荐
- 衰弱评估采用Fried标准,肌少症诊断采用欧洲老年人肌少症工作组(EWGSOP)标准。
- BMR<1612 kcal/d对应更高的衰弱与肌少症频率。
- BMR/BSA截断值874 kcal/m2诊断肌少症敏感度80%、特异度68%,AUC 0.82。
临床怎么用
- 对老年男性低BMR者应 alert 筛查肌少症与衰弱。
- 可考虑用BMR/BSA作为老年男性肌少症的客观筛查辅助指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim of this study is to demonstrate the ability of the basal metabolic rate (BMR) to detect frailty and sarcopenia in older males. SETTING AND PARTICIPANTS: A total of 305 male patients undergoing comprehensive geriatric assessment were included in the study. MEASURES: The frailty status was assessed with the Fried criteria. Sarcopenia was diagnosed according to the European Working Group on Sarcopenia in Older People criteria. BMR is calculated by bioimpedance analysis. Areas under the curves (AUCs) of receiver operating characteristic analyses were used to test the predictive accuracy of BMR in detecting sarcopenia. RESULTS: The mean age was 74.52 ± 7.51 years. Among the patients in the sample, 95 (31.1%) had sarcopenia and 55 (18%) had frailty. Patients who had a BMR <1612 kcal/d had a higher frequency of frailty than those who had a BMR ≥1612 kcal/d (67.3 vs 32.7, P < .001). Results were similar for sarcopenia (77.9 vs 22.1, P < .001). When BMR was divided by body surface area (BSA), BMR/BSA with a cut-off of 874 kcal/m2 had a sensitivity of 80% and a specificity of 68%, and the AUC was 0.82 for BMR/BSA, in diagnosing sarcopenia (P < .01). The participants without sarcopenia had a higher BMR/BSA for the unadjusted (OR = 8.00, 95% CI 4.52-14.19, P < .001) and adjusted analyses (OR = 6.60, 95% CI 3.52-12.38, P < .001). CONCLUSIONS: Older male patients with sarcopenia and frailty have a higher BMR reduction. Therefore, it should be kept in mind that patients with low BMR should alert us to screen sarcopenia and frailty. BMR/BSA may play a role in objective screening to detect sarcopenia in older males.
引用
- Soysal P, Ates Bulut E, Yavuz I, et al. Decreased Basal Metabolic Rate Can Be an Objective Marker for Sarcopenia and Frailty in Older Males. J Am Med Dir Assoc. 2018. PMID: 30122323. doi:10.1016/j.jamda.2018.07.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。